QA: Celgene CORP DE in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2019_Celgene_CORP_DE.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 9,067,000,000
1 IntangibleAssetsNetIncludingGoodwill 24,213,000,000
2 PropertyPlantAndEquipmentNet 1,367,000,000
3 remainder_Assets 833,000,000
4 LiabilitiesCurrent 4,057,000,000
5 LiabilitiesNoncurrent 20,319,000,000
6 remainder_Liabilities 4,943,000,000
7 CostOfGoodsAndServicesSold 587,000,000
8 SellingGeneralAndAdministrativeExpense 3,417,638,311
9 ResearchAndDevelopmentExpense 5,553,884,334
10 remainder_Expenses 1,619,769,957
11 remainder_Revenues 17,414,192,410
12 remainder_NetIncome 330,258,976
13 remainder_ComprehensiveNetIncome 171,979,151
  yvar yval
0 Assets 35,480,000,000
1 Liabilities 29,319,000,000
2 Expenses 11,178,292,602
3 Revenues 17,414,192,410
4 StockholdersEquity 6,161,000,000
5 NetIncome 6,566,158,784
6 ComprehensiveNetIncome 6,652,148,360
7 BaseVar 46,946,861,570
8 EconomicCapitalRatiobeforeLimitedLiability 0.620
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time